Bank of America’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.9M Sell
1,329,251
-85,258
-6% -$1.19M ﹤0.01% 2333
2026
Q1
$13.3M Buy
1,414,509
+589,408
+71% +$6.47M ﹤0.01% 2735
2025
Q4
$10.2M Buy
825,101
+201,021
+32% +$2.67M ﹤0.01% 2832
2025
Q3
$8.94M Sell
624,080
-36,083
-5% -$494K ﹤0.01% 3417
2025
Q2
$8.1M Sell
660,163
-174,844
-21% -$2.54M ﹤0.01% 3416
2025
Q1
$18.4M Buy
835,007
+243,143
+41% +$5.72M ﹤0.01% 2533
2024
Q4
$13.4M Sell
591,864
-202,869
-26% -$4.43M ﹤0.01% 2656
2024
Q3
$14.4M Buy
794,733
+264,772
+50% +$6.14M ﹤0.01% 2711
2024
Q2
$15.4M Buy
529,961
+115,928
+28% +$3.44M ﹤0.01% 2503
2024
Q1
$14.7M Sell
414,033
-18,885
-4% -$755K ﹤0.01% 2594
2023
Q4
$18.9M Sell
432,918
-69,641
-14% -$2.74M ﹤0.01% 2216
2023
Q3
$19.2M Buy
502,559
+10,844
+2% +$456K ﹤0.01% 2070
2023
Q2
$20.2M Sell
491,715
-170,535
-26% -$8.21M ﹤0.01% 2033
2023
Q1
$38M Buy
662,250
+134,367
+25% +$7.57M ﹤0.01% 1572
2022
Q4
$29.6M Buy
527,883
+1,972
+0.4% +$100K ﹤0.01% 1694
2022
Q3
$22.3M Sell
525,911
-7,282
-1% -$373K ﹤0.01% 1863
2022
Q2
$28.8M Buy
533,193
+59,497
+13% +$3.57M ﹤0.01% 1702
2022
Q1
$30.4M Buy
473,696
+32,930
+7% +$2.17M ﹤0.01% 1765
2021
Q4
$29.5M Buy
440,766
+32,036
+8% +$2.17M ﹤0.01% 1860
2021
Q3
$28M Buy
408,730
+83,274
+26% +$5.88M ﹤0.01% 1850
2021
Q2
$22.2M Sell
325,456
-6,072
-2% -$429K ﹤0.01% 2048
2021
Q1
$22.9M Buy
331,528
+14,868
+5% +$1.01M ﹤0.01% 1919
2020
Q4
$20.6M Sell
316,660
-41,710
-12% -$2.24M ﹤0.01% 1863
2020
Q3
$16.9M Sell
358,370
-21,412
-6% -$1.02M ﹤0.01% 1855
2020
Q2
$17.8M Buy
379,782
+105,049
+38% +$5.16M ﹤0.01% 1701
2020
Q1
$12.3M Buy
274,733
+45,703
+20% +$2.4M ﹤0.01% 1885
2019
Q4
$13.3M Sell
229,030
-10,539
-4% -$627K ﹤0.01% 2269
2019
Q3
$14.4M Buy
239,569
+16,101
+7% +$959K ﹤0.01% 2144
2019
Q2
$12.5M Sell
223,468
-55,465
-20% -$2.86M ﹤0.01% 2304
2019
Q1
$15.5M Buy
278,933
+96,948
+53% +$4.94M ﹤0.01% 2066
2018
Q4
$8.21M Sell
181,985
-83,602
-31% -$4.59M ﹤0.01% 2497
2018
Q3
$17.5M Sell
265,587
-54,001
-17% -$3.36M ﹤0.01% 1946
2018
Q2
$20.6M Sell
319,588
-52,641
-14% -$3.26M ﹤0.01% 1789
2018
Q1
$20.6M Sell
372,229
-166,933
-31% -$8.75M ﹤0.01% 1745
2017
Q4
$25.8M Sell
539,162
-64,643
-11% -$3.16M ﹤0.01% 1597
2017
Q3
$30.5M Buy
603,805
+176,055
+41% +$9.04M ﹤0.01% 1530
2017
Q2
$23.3M Sell
427,750
-91,448
-18% -$4.37M ﹤0.01% 1600
2017
Q1
$21.9M Buy
519,198
+187,838
+57% +$8.03M ﹤0.01% 1678
2016
Q4
$14.2M Buy
331,360
+50,700
+18% +$2.06M ﹤0.01% 1988
2016
Q3
$11.6M Buy
280,660
+126,942
+83% +$5.32M ﹤0.01% 2103
2016
Q2
$6.13M Buy
153,718
+10,304
+7% +$371K ﹤0.01% 2627
2016
Q1
$4.83M Sell
143,414
-74,534
-34% -$2.32M ﹤0.01% 2812
2015
Q4
$7.38M Sell
217,948
-16,132
-7% -$504K ﹤0.01% 2558
2015
Q3
$6.97M Buy
234,080
+139,996
+149% +$4.38M ﹤0.01% 2549
2015
Q2
$2.59M Buy
94,084
+78,192
+492% +$2.08M ﹤0.01% 3207
2015
Q1
$401K Sell
15,892
-20,761
-57% -$491K ﹤0.01% 4471
2014
Q4
$813K Buy
36,653
+24,673
+206% +$500K ﹤0.01% 4218
2014
Q3
$242K Sell
11,980
-287
-2% -$5.71K ﹤0.01% 5221
2014
Q2
$236K Sell
12,267
-34,228
-74% -$638K ﹤0.01% 5400
2014
Q1
$874K Sell
46,495
-15,386
-25% -$297K ﹤0.01% 4041
2013
Q4
$1.21M Buy
61,881
+6,948
+13% +$127K ﹤0.01% 3863
2013
Q3
$904K Sell
54,933
-46,483
-46% -$746K ﹤0.01% 4040
2013
Q2
$1.52M Buy
+101,416
New +$1.49M ﹤0.01% 3528

Other funds holding IART

Bank of America's IART Position: Q2 2026 in Review

Bank of America reduced its Integra LifeSciences (IART) stake by 6% in Q2 2026, selling an estimated $1.19M and leaving 1,329,251 shares worth $23.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2333.

Bank of America first reported a position in IART in Q2 2013 and has held it in 53 quarters since. The position peaked at $38M in Q1 2023. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Bank of America held 1,329,251 shares of Integra LifeSciences worth $23.9M as of Q2 2026.
  • Bank of America sold 85,258 Integra LifeSciences shares in Q2 2026, an estimated $1.19M.
  • Integra LifeSciences made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #2333 holding.
  • Bank of America first reported a position in Integra LifeSciences in Q2 2013 and has held it in 53 quarters since.
  • Bank of America's Integra LifeSciences position peaked at $38M in Q1 2023.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.